Pharma’s manufacturing moment: Where companies are making the biggest moves
PharmaVoice
APRIL 11, 2025
The tariff war has prompted new calls to reshore manufacturing. Several large pharmas have already made the leap.
Fri.Apr 11, 2025
259 
Payer Advocates Applaud 5% MA Payment Increase
MedCity News
APRIL 11, 2025
CMS recently announced that payments to Medicare Advantage plans will increase by 5.06%, drawing support from payer advocates. The post Payer Advocates Applaud 5% MA Payment Increase appeared first on MedCity News.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA to phase out animal testing with AI and lab-based models
Pharmaceutical Technology
APRIL 11, 2025
The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.
The Top 6 Best Analytics Tools for Health Care Revenue in 2025
MedCity News
APRIL 11, 2025
[Sponsored] Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources. The post The Top 6 Best Analytics Tools for Health Care Revenue in 2025 appeared first on MedCity News.
State of AI in Sales & Marketing 2025
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
Pharmaceutical Technology
APRIL 11, 2025
The twice daily tablet represents a significant step forward for patients with advanced breast cancer.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Novartis to Expand US-Based R&D and Manufacturing
PharmaTech
APRIL 11, 2025
The company has plans to invest $23 billion during the next five years to expand manufacturing and R&D in the US, which will include seven new facilities.
FDA plans to phase out animal testing for antibodies
pharmaphorum
APRIL 11, 2025
The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.
Pharma Pulse 4/11/25: Long-Term Sustainability for Diverse Trial Initiatives, Payers Consider Policy Options for GLP-1 Access & more
Pharmaceutical Commerce
APRIL 11, 2025
The latest news for pharma industry insiders.
Alzheon Alzheimer's hopes dented by trial readout
pharmaphorum
APRIL 11, 2025
Alzheon has been left sifting through data from a failed Alzheimer's trial for crumbs of evidence that its oral therapy may have some efficacy
The Intersection of AI and Sales: Personalization Without Compromise
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Hubs East 2025: Building a Thriving Culture
Pharmaceutical Commerce
APRIL 11, 2025
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, comments on another presentation that has caught her eye at the conference.
RFK Jr unorthodox vaccine views on show in interview
pharmaphorum
APRIL 11, 2025
Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview that touched on delays to a COVID-19 shot review
BDD Opens GMP Manufacturing Facility in Scotland
PharmaTech
APRIL 11, 2025
Development of the state-of-the-art facility was made possible by a 2 million (US$2.6 million) round of funding, and a successful inspection by MHRA was completed in March 2025.
Pill that can slow breast cancer cleared for NHS use
pharmaphorum
APRIL 11, 2025
AstraZeneca's oral drug Truqap will soon be available for people with advanced breast cancer via the NHS in England, as long as testing is available
The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Novartis to Invest $23 Billion in US Manufacturing and R&D Over Five Years
PharmExec
APRIL 11, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Can AI replace medical writers? Experts say not immediately
Pharmaceutical Technology
APRIL 11, 2025
AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.
From Prescription to Patient: Four Ways to Increase Speed to Therapy
Pharmaceutical Commerce
APRIL 11, 2025
The key strategies for reducing or eliminating post-prescription abandonment.
FDA Grants Full Approval to Bayer’s Vitrakvi for NTRK Gene Fusion-Positive Solid Tumors
PharmExec
APRIL 11, 2025
Full approval of Vitrakvi was based on results from three clinical trials in patients with unresectable or metastatic NTRK fusion-positive solid tumors.
AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
What Your Data Can Tell You About Illicit Trade Risk
Pharmaceutical Commerce
APRIL 11, 2025
Why taking proactive stepsand combing the right data sourcesis critical to informed decision-making in risk management.
Pharma Pulse 4/11/25: Reimagining Operations to Deliver the Future of Personalized Medicine, Federal Marijuana Movement Hits the Brakes & more
PharmExec
APRIL 11, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
LogiPharma Europe 2025: Harnessing Technology to Advance Operations and Patient Impact
Pharmaceutical Commerce
APRIL 11, 2025
Steffen Lang, president, operations, executive committee member, Novartis, discusses how technology will continue to enhance operations and how it will impact patients.
Pluri’s immune cell expansion technologies gain patents
Pharmaceutical Technology
APRIL 11, 2025
Pluri has announced the issuance of a patent by the US Patent and Trademark Office (USPTO) for its immune cell expansion technologies.
5 Ways You Can Win Faster with Gen AI in Sales
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Expanding Disease Indications for JUV-161
PharmExec
APRIL 11, 2025
Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, discusses Juvenas "pipeline in a product" JUV-161 and plans to broaden into other disease indications.
NMPA approves BBM and Takeda China’s haemophilia B therapy
Pharmaceutical Technology
APRIL 11, 2025
Belief BioMed (BBM) and Takeda China have announced the receipt of Chinas NMPA approval for BBM-H901for treating haemophilia B
Johnson & Johnson’s Icotrokinra Demonstrates Significant Skin Clearance in Adolescents with Moderate-to-Severe Plaque Psoriasis
PharmExec
APRIL 11, 2025
In the Phase III ICONIC-LEAD trial, 75% of adolescents with moderate-to-severe plaque psoriasis treated with icotrokinra achieved completely clear skin by week 24.
FDA approves Biocon Biologics’ bevacizumab biosimilar for cancer
Pharmaceutical Technology
APRIL 11, 2025
Biocon Biologics has received approval from the US Food and Drug Administration for the intravenous use of Jobevne (bevacizumab-nwgd).
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
A Question of Soul: A Pharmacist Confronts Himself and His Profession
Pharmacy Times
APRIL 11, 2025
In business, growth for the sake of growth mirrors the ideology of the cancer cell.
Can AI replace medical writers? Experts say not immediately
Pharmaceutical Technology
APRIL 11, 2025
AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.
Lower Vitamin K Levels Associated with Impaired Learning and Memory in Mice
Pharmacy Times
APRIL 11, 2025
Rather than turning to vitamin K supplements, individuals should incorporate more vegetables into their diets.
Let's personalize your content